Latest news
Loading news…
Imbruvica
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring). South San Francisco, California, United States Founded 2013 11-50 employees For Profit
Imbruvica is an oral medicine for treating CLL, SLL, and MCL by blocking BTK protein in cancer cells.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 17
- IT spend
- $15K
Company Info
- Founded
- 2013
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 5
- HQ
- South San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
Signals & Scores
- Heat score
- High
- Trend (7d)
- 1
- Trend (30d)
- 0.3
- Trend (90d)
- -2.5
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Imbruvica
Loading news…
FAQs about Imbruvica
People who checked this page also checked these
Browse the full Acquirezy directory.